Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 33.18% is 16% above its 5-year average of 28.72%, near the high end of its 5-year range (12.69%–40.08%).
3.05% above its 12-month average of 32.20%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 34.95%.
OPERATING MARGIN
33.18%
OPERATING MARGIN AVG TTM
32.20%
OPERATING MARGIN AVG 3Y
26.48%
OPERATING MARGIN AVG 5Y
28.72%
OPERATING MARGIN AVG 10Y
35.30%
OPERATING MARGIN AVG 15Y
34.46%
OPERATING MARGIN AVG 20Y
35.16%
CURRENT VS TTM AVG
+3.05%
CURRENT VS 3Y AVG
+25.31%
CURRENT VS 5Y AVG
+15.52%
CURRENT VS 10Y AVG
-6.02%
CURRENT VS 15Y AVG
-3.71%
CURRENT VS 20Y AVG
-5.63%
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+122.68%
vs the sector median at left
Market Cap
$189.15B
Operating Margin
43.10%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
Market Cap
$179.63B
Operating Margin
39.74%
TTM Avg
22.76%
3Y Avg
25.11%
5Y Avg
25.54%
Market Cap
$176.57B
Operating Margin
17.03%
TTM Avg
17.21%
3Y Avg
17.41%
5Y Avg
17.71%
Market Cap
$233.32B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$252.35B
Operating Margin
22.77%
TTM Avg
20.95%
3Y Avg
17.06%
5Y Avg
15.08%
Market Cap
$144.68B
Operating Margin
20.42%
TTM Avg
21.31%
3Y Avg
23.25%
5Y Avg
23.28%
Market Cap
$130.54B
Operating Margin
31.28%
TTM Avg
28.70%
3Y Avg
26.89%
5Y Avg
27.25%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amgen Inc. (AMGN) | $202.99B | 33.18% | 32.20% | 26.48% | 28.72% |
| Novo Nordisk A/S (NVO)vs › | $189.15B | 43.10% | 42.74% | 42.98% | 42.70% |
| Gilead Sciences, Inc. (GILD)vs › | $179.63B | 39.74% | 22.76% | 25.11% | 25.54% |
| Abbott Laboratories (ABT)vs › | $176.57B | 17.03% | 17.21% | 17.41% | 17.71% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $233.32B | 17.69% | 18.04% | 18.11% | 20.54% |
| Pfizer Inc. (PFE)vs › | $156.85B | 25.08% | 25.29% | 24.23% | 24.05% |
| AstraZeneca PLC (AZN)vs › | $252.35B | 22.77% | 20.95% | 17.06% | 15.08% |
| Danaher Corporation (DHR)vs › | $144.68B | 20.42% | 21.31% | 23.25% | 23.28% |
| Intuitive Surgical, Inc. (ISRG)vs › | $130.54B | 31.28% | 28.70% | 26.89% | 27.25% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 38.59% | 18.66% | 31.09% | 34.52% |
Gross Margin
72.7%
Operating Margin
33.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 34.95% |
| 2026-03-31 | 30.94% |
| 2025-12-31 | 39.83% |
| 2025-09-30 | 26.43% |
| 2025-06-30 | 28.84% |
| 2025-03-31 | 14.46% |
| 2024-12-31 | 25.43% |
| 2024-09-30 | 24.07% |
| 2024-06-30 | 22.76% |
| 2024-03-31 | 13.31% |
| 2023-12-31 | 15.51% |
| 2023-09-30 | 29.28% |
| 2023-06-30 | 38.42% |
| 2023-03-31 | 31.47% |
| 2022-12-31 | 32.61% |
| 2022-09-30 | 39.99% |
| 2022-06-30 | 33.00% |
| 2022-03-31 | 40.08% |
| 2021-12-31 | 33.65% |
| 2021-09-30 | 35.46% |
| 2021-06-30 | 12.69% |
| 2021-03-31 | 36.08% |
| 2020-12-31 | 30.27% |
| 2020-09-30 | 38.19% |
| 2020-06-30 | 37.43% |
| 2020-03-31 | 38.22% |
| 2019-12-31 | 33.05% |
| 2019-09-30 | 43.16% |
| 2019-06-30 | 45.61% |
| 2019-03-31 | 44.48% |
| 2018-12-31 | 38.23% |
| 2018-09-30 | 39.35% |
| 2018-06-30 | 46.74% |
| 2018-03-31 | 49.08% |
| 2017-12-31 | 38.69% |
| 2017-09-30 | 42.25% |
| 2017-06-30 | 46.44% |
| 2017-03-31 | 47.42% |
| 2016-12-31 | 41.66% |
| 2016-09-30 | 43.49% |
| 2016-06-30 | 41.84% |
| 2016-03-31 | 43.46% |
| 2015-12-31 | 36.72% |
| 2015-09-30 | 40.87% |
| 2015-06-30 | 38.66% |
| 2015-03-31 | 40.17% |
| 2014-12-31 | 27.37% |
| 2014-09-30 | 29.14% |
| 2014-06-30 | 36.72% |
| 2014-03-31 | 30.17% |
| 2013-12-31 | 23.69% |
| 2013-09-30 | 35.55% |
| 2013-06-30 | 33.13% |
| 2013-03-31 | 34.03% |
| 2012-12-31 | 24.61% |
| 2012-09-30 | 32.95% |
| 2012-06-30 | 35.49% |
| 2012-03-31 | 36.49% |
| 2011-12-31 | 29.25% |
| 2011-09-30 | 13.31% |
| 2011-06-30 | 33.64% |
| 2011-03-31 | 34.89% |
| 2010-12-31 | 27.81% |
| 2010-09-30 | 38.76% |
| 2010-06-30 | 39.88% |
| 2010-03-31 | 41.23% |
| 2009-12-31 | 29.48% |
| 2009-09-30 | 42.10% |
| 2009-06-30 | 39.24% |
| 2009-03-31 | 39.93% |
| 2008-12-31 | 30.31% |
| 2008-09-30 | 38.27% |
| 2008-06-30 | 31.32% |
| 2008-03-31 | 39.16% |
| 2007-12-31 | 28.22% |
| 2007-09-30 | 10.88% |
| 2007-06-30 | 30.31% |
| 2007-03-31 | 37.97% |
| 2006-12-31 | 25.79% |
| 2006-09-30 | 36.60% |
| 2006-06-30 | 8.19% |
| 2006-03-31 | 38.36% |
| 2005-12-31 | 33.66% |
| 2005-09-30 | 41.15% |
| 2005-06-30 | 40.76% |
| 2005-03-31 | 40.80% |
| 2004-12-31 | 31.59% |
| 2004-09-30 | 18.21% |
| 2004-06-30 | 38.96% |
| 2004-03-31 | 39.61% |
| 2003-12-31 | 32.18% |
| 2003-09-30 | 38.82% |
| 2003-06-30 | 40.03% |
| 2003-03-31 | 37.60% |
| 2002-12-31 | 438.45% |
| 2002-09-30 | -163.95% |
